Senzime has submitted application for cross-trading at OTCQX in the US
Kurs & Likviditet
Prenumeration
Kalender
| 2024-11-06 | Kvartalsrapport 2024-Q3 |
| 2024-10-23 | Extra Bolagsstämma 2024 |
| 2024-08-26 | Kvartalsrapport 2024-Q2 |
| 2024-05-17 | X-dag ordinarie utdelning SEZI 0.00 SEK |
| 2024-05-16 | Årsstämma |
| 2024-05-07 | Kvartalsrapport 2024-Q1 |
| 2024-02-15 | Bokslutskommuniké 2023 |
| 2023-11-28 | Extra Bolagsstämma 2023 |
| 2023-10-26 | Kvartalsrapport 2023-Q3 |
| 2023-08-24 | Kvartalsrapport 2023-Q2 |
| 2023-05-17 | X-dag ordinarie utdelning SEZI 0.00 SEK |
| 2023-05-16 | Årsstämma |
| 2023-04-28 | Kvartalsrapport 2023-Q1 |
| 2023-02-20 | Bokslutskommuniké 2022 |
| 2023-02-16 | Extra Bolagsstämma 2022 |
| 2022-11-10 | Kvartalsrapport 2022-Q3 |
| 2022-07-15 | Kvartalsrapport 2022-Q2 |
| 2022-05-19 | X-dag ordinarie utdelning SEZI 0.00 SEK |
| 2022-05-18 | Årsstämma |
| 2022-05-05 | Kvartalsrapport 2022-Q1 |
| 2022-02-17 | Bokslutskommuniké 2021 |
| 2021-11-12 | Kvartalsrapport 2021-Q3 |
| 2021-08-27 | Kvartalsrapport 2021-Q2 |
| 2021-05-12 | X-dag ordinarie utdelning SEZI 0.00 SEK |
| 2021-05-11 | Årsstämma |
| 2021-05-06 | Kvartalsrapport 2021-Q1 |
| 2021-03-05 | Extra Bolagsstämma 2021 |
| 2021-02-26 | Bokslutskommuniké 2020 |
| 2020-11-06 | Kvartalsrapport 2020-Q3 |
| 2020-08-21 | Kvartalsrapport 2020-Q2 |
| 2020-07-02 | Extra Bolagsstämma 2020 |
| 2020-05-15 | X-dag ordinarie utdelning SEZI 0.00 SEK |
| 2020-05-14 | Årsstämma |
| 2020-05-08 | Kvartalsrapport 2020-Q1 |
| 2020-02-14 | Bokslutskommuniké 2019 |
| 2019-11-08 | Kvartalsrapport 2019-Q3 |
| 2019-08-22 | Kvartalsrapport 2019-Q2 |
| 2019-08-21 | Extra Bolagsstämma 2019 |
| 2019-05-09 | X-dag ordinarie utdelning SEZI 0.00 SEK |
| 2019-05-08 | Årsstämma |
| 2019-05-08 | Kvartalsrapport 2019-Q1 |
| 2019-02-15 | Bokslutskommuniké 2018 |
| 2018-11-08 | Kvartalsrapport 2018-Q3 |
| 2018-08-22 | Kvartalsrapport 2018-Q2 |
| 2018-05-09 | X-dag ordinarie utdelning SEZI 0.00 SEK |
| 2018-05-08 | Årsstämma |
| 2018-05-08 | Kvartalsrapport 2018-Q1 |
| 2018-03-05 | Extra Bolagsstämma 2018 |
| 2018-02-16 | Bokslutskommuniké 2017 |
| 2017-11-28 | Kvartalsrapport 2017-Q3 |
| 2017-09-15 | Extra Bolagsstämma 2017 |
| 2017-08-31 | Kvartalsrapport 2017-Q2 |
| 2017-05-23 | Kvartalsrapport 2017-Q1 |
| 2017-05-23 | Årsstämma |
| 2017-02-16 | Bokslutskommuniké 2016 |
| 2016-11-22 | Kvartalsrapport 2016-Q3 |
| 2016-08-31 | Kvartalsrapport 2016-Q2 |
| 2016-05-17 | Extra Bolagsstämma 2016 |
| 2016-04-28 | X-dag ordinarie utdelning SEZI 0.00 SEK |
| 2016-04-27 | Årsstämma |
| 2016-04-27 | Kvartalsrapport 2016-Q1 |
| 2016-02-18 | Bokslutskommuniké 2015 |
| 2015-11-24 | Kvartalsrapport 2015-Q3 |
| 2015-08-26 | Kvartalsrapport 2015-Q2 |
| 2015-05-20 | X-dag ordinarie utdelning SEZI 0.00 SEK |
| 2015-05-19 | Årsstämma |
| 2015-05-19 | Kvartalsrapport 2015-Q1 |
| 2015-02-25 | Bokslutskommuniké 2014 |
| 2014-11-27 | Kvartalsrapport 2014-Q3 |
| 2014-11-21 | Extra Bolagsstämma 2014 |
| 2014-08-21 | Kvartalsrapport 2014-Q2 |
| 2014-05-15 | X-dag ordinarie utdelning SEZI 0.00 SEK |
| 2014-05-14 | Årsstämma |
| 2014-05-14 | Kvartalsrapport 2014-Q1 |
| 2014-02-24 | Bokslutskommuniké 2013 |
| 2013-11-27 | Kvartalsrapport 2013-Q3 |
| 2013-08-20 | Kvartalsrapport 2013-Q2 |
| 2013-05-16 | X-dag ordinarie utdelning SEZI 0.00 SEK |
| 2013-05-15 | Årsstämma |
| 2013-05-15 | Kvartalsrapport 2013-Q1 |
| 2013-02-28 | Bokslutskommuniké 2012 |
| 2013-01-08 | Extra Bolagsstämma 2013 |
| 2012-11-21 | Kvartalsrapport 2012-Q3 |
| 2012-08-21 | Kvartalsrapport 2012-Q2 |
| 2012-05-24 | X-dag ordinarie utdelning SEZI 0.00 SEK |
| 2012-05-23 | Årsstämma |
| 2012-05-23 | Kvartalsrapport 2012-Q1 |
| 2012-02-22 | Bokslutskommuniké 2011 |
| 2011-11-23 | Kvartalsrapport 2011-Q3 |
| 2011-08-23 | Kvartalsrapport 2011-Q2 |
| 2011-05-27 | X-dag ordinarie utdelning SEZI 0.00 SEK |
| 2011-05-26 | Årsstämma |
| 2011-05-26 | Kvartalsrapport 2011-Q1 |
| 2011-02-16 | Bokslutskommuniké 2010 |
| 2010-11-24 | Kvartalsrapport 2010-Q3 |
| 2010-05-28 | X-dag ordinarie utdelning SEZI 0.00 SEK |
| 2010-05-27 | Kvartalsrapport 2010-Q1 |
| 2009-11-25 | Kvartalsrapport 2009-Q3 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Small Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Senzime, an industry leader in algorithm-based patient monitoring solutions announces the submission of an application for cross-trading of the Senzime share on the OTCQX trading platform. Upon approval, Senzimes shares will in parallel to its current Nasdaq Main Market listing, be traded with a US ticker symbol and a share price in USD.
OTCQX is a trading platform in the United States operated by the OTC Markets Group, as an alternative to listing on Nasdaq New York and NYSE. Cross-trading on OTCQX helps satisfy an increasing interest from US investors and increase accessibility to the US capital market. Upon approval, Senzimes shares will be traded with a US ticker symbol and a share price in USD, during US market hours.
"Around 15 percent of the shares in Senzime are held by US investors, and the majority of our revenues are generated from the US market. As a result, we want to make it easier for US investors to trade in the Senzime share”, comments Philip Siberg, CEO of Senzime AB.
For further information, please contact:
Philip Siberg, CEO of Senzime AB
Phone: +46 (0) 707 90 67 34, e-mail: philip.siberg@senzime.com
Slavoljub Grujicic, CFO
Phone: +46 (0) 76 306 60 11, e-mail: slavoljub.grujicic@senzime.com
About Senzime
Senzime is a Swedish medical device company that develops, manufactures, and markets CE- and FDA-cleared patient monitoring systems. Senzime’s employees worldwide are committed to the vision of a world without anesthesia- and respiratory-related complications. The company markets an innovative portfolio of solutions, including the TetraGraph® and ExSpiron® 2Xi for real-time monitoring of neuromuscular and respiratory functions, typically under and after surgery. The goal is to help eliminate in-hospital complications, and radically reduce health care costs related to surgical and high acuity procedures.
Senzime targets a market opportunity valued more than SEK 40 billion per year, and operates with sales teams in the world’s leading markets. The company’s shares are listed on Nasdaq Stockholm Main Market (SEZI). More information is available at senzime.com.